20:19 , Feb 23, 2018 |  BC Week In Review  |  Company News

USAID unveils project to prevent viral pandemics

In a policy paper published in...
23:56 , Dec 19, 2017 |  BC Extra  |  Politics & Policy

Federal funding ban lifted for pathogen research

NIH said a three-year long federal pause on funding for gain of function (GOF) research on pathogens has been lifted. The green light came after HHS published a framework Tuesday to guide agency funding decisions...
20:59 , Jul 18, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Coronavirus; SARS-associated coronavirus Cell culture and mouse studies suggest the nucleotide analog GS-5734 could help treat or prevent severe acute respiratory syndrome (SARS), Middle East respiratory syndrome coronavirus (MERS-CoV) and coronavirus NL63 infections. In...
00:28 , Mar 31, 2017 |  BC Innovations  |  Targets & Mechanisms

Cells on the rise

This year’s meeting of the American Association for Cancer Research (AACR) will keep the spotlight on immuno-oncology, where preclinical science is continuing to expand the use of different types of innate and adaptive immune cells...
07:00 , Oct 20, 2016 |  BC Innovations  |  Product R&D

Sirtuins forge ahead

Since sirtuins hit the scene as modulators of numerous cellular pathways over 20 years ago, the enzymes have been implicated in metabolic diseases, aging and cancer. Now Forge Life Science LLC has licensed findings from...
07:00 , Aug 1, 2016 |  BioCentury  |  Strategy

Bug battle plan

Tired of waiting for the international community to organize proactive responses to the threats posed by emerging infectious diseases, GlaxoSmithKline plc has developed plans and is soliciting government support to create a permanent, independent entity...
07:00 , Jun 30, 2016 |  BC Innovations  |  Translation in Brief

Inverted immunity

A cohort of interferon-stimulated gene 15 ( ISG15 )-deficient adolescents has revealed the protein has opposite roles in the viral immunities of mice and humans, and produced data suggesting inhibitors could provide a broad therapeutic...
07:00 , Apr 28, 2016 |  BC Innovations  |  Strategy

Throw CRISPR into a pool

Steve Usdin, Washington Editor, C. Simone Fishburn, Editor, BioCentury Innovations  The scientists involved in disputes over CRISPR- Cas9 patents, and the institutions and companies they are affiliated with, should find a way to stop squabbling...
07:00 , Mar 31, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Interferon α/β receptor 1 (IFNAR1); tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Infectious disease INDICATION: Acute lung injury; respiratory distress syndrome (RDS) Cell culture and mouse studies suggest that combining inhibitors of IFNAR1 and TRAIL could help treat acute respiratory distress syndrome (ARDS) and other types of...
08:00 , Feb 15, 2016 |  BioCentury  |  Politics, Policy & Law

Crushing need

If pathogens could be crushed to death under the weight of thoughtful, well-crafted reports, the world would be a much safer place. Eminent scientists have been holding meetings and writing reports for over 20 years...